Research · Three times every trading day, once on weekend days
Research reports
The day's biggest market stories explained with numbers: why a stock or the market moved, what the filings say, how it has traded before, with charts and sources. Written by the Quantisnow Research Desk from Quantisnow wire data. RSS
- Quantum stocks bounce off yearly lows as IonQ and Quantinuum raise forecastsNov 7, 2026Quantinuum rose 26.1% and IonQ 22.5% on Nov 6, while the S&P 500 ETF gained 0.27%. Quantinuum still trades near 300 times this year's expected sales.IONQQNTQBTSSPY
- Atlassian drops 16% after forecasting slower growth as JFrog rallies on its outlookNov 6, 2026Atlassian beat revenue and earnings estimates, but its outlook raised the year by less than the beat and set a fiscal year-end subscription ARR growth target of about 18.5%, down from 23%.TEAMFROGDDOGIGV
- Chip stocks have their worst day since 2020 as the postelection rally reversesNov 5, 2026The Nasdaq 100 fell 6.3% and the S&P 500 4.3%, while communication services, utilities and staples each fell less than 1%.SMHQQQSPYRSP
- CVS sheds nearly $15 billion as a breakup plan lands alongside a raised forecastNov 5, 2026CVS fell 12.6% while health care stocks rose 3.1%. The split plan came with no debt allocation, and management called 2027 the trough year for pharmacy-benefit profits.CVSUNHCI
- Dow has its best day since April 2025 as markets absorb a Democratic CongressNov 4, 2026Oil fell about 8% and AI-infrastructure stocks slid on worries about Washington and Texas, while the average S&P 500 stock closed at a 52-week high.DIASPYQQQRSP
- Oracle rises 6% after selling $20 billion of stock and bonds at coupons up to 8.65%Nov 4, 2026The 86.2 million new shares add about 2.8% to Oracle's share count, and the deal equals the $20 billion limit on new capital that Oracle set on Oct. 28.ORCLBE
- Stevanato's 29% drop followed a warning that GLP-1 volumes will slow 2027 growthNov 3, 2026Q3 revenue rose 8% and Stevanato kept its 2026 guidance, but it now expects low single-digit growth in 2027, short of the high single to low double digits in its long-range plan.STVNSHCWST
- Lumentum's 18.7% drop on a strong quarter tracked Marvell's shrinking offerNov 3, 2026Lumentum's adjusted EPS beat the top of its own range by 22 cents. By Monday's close, Marvell's offer was worth 8.3% less than Lumentum's Friday share price.LITEMRVLAAOISOXX
- IDEXX jumps 22% as investors pay up for testing growth that outruns clinic trafficNov 2, 2026The $0.25 raise to IDEXX's 2026 EPS guide is worth about $11 a share at the new multiple, but the stock gained $120.58, moving it from 37 to 45 times guided earnings.IDXXZTSSPY
- Intel's 29% plunge explains less than a fifth of the Nasdaq 100's 3.5% slideNov 2, 2026Most of the drop came from a wider chip selloff that cut the semiconductor fund 6.9% on Oct. 30, its worst day since June.INTCSNDKAPPQQQ
